A Prospective Cohort With Patient Navigation as an Intervention for Breast Cancer Patients

NCT06257888 · Status: COMPLETED · Type: OBSERVATIONAL · Enrollment: 90

Last updated 2025-09-11

No results posted yet for this study

Summary

The objective of this observational study is to introduce a patient navigation system within the breast cancer unit at Hospital Central de Maputo (MOZ) and gather data to assess the efficacy of patient navigation in enhancing oncological outcomes among this patient cohort. The primary inquiries it seeks to address are as follows:

* Can patient navigation reduce the duration (in days) between patient admission and the commencement of treatment?
* Does patient navigation influence overall survival rates when juxtaposed with historical cohorts from the local setting? Participants will receive continuous support from a patient navigator starting from admission until the initiation of any oncological treatment.

Conditions

  • Breast Neoplasm Malignant Primary

Interventions

OTHER

patient navigation

two trained patient navigators will admit breast cancer patients to HCM, navigate them from admission to commencement of first treatment and will collect all pertinent epidemiological data and variables

Sponsors & Collaborators

  • AMERICAN SOCIETY FOR CLINICAL PATHOLOGY

    collaborator UNKNOWN
  • Hospital Central de Maputo

    collaborator UNKNOWN
  • Eduardo Mondlane University

    collaborator OTHER
  • M.D. Anderson Cancer Center

    collaborator OTHER
  • Renato Cagnacci Neto

    lead OTHER

Principal Investigators

  • renato cagnacci neto, MD, MSc · AC Camargo Cancer Center

Eligibility

Min Age
18 Years
Sex
FEMALE
Healthy Volunteers
Yes

Timeline & Regulatory

Start
2024-03-01
Primary Completion
2025-04-01
Completion
2025-05-01

Countries

  • Mozambique

Study Locations

More Related Trials

Read the full study record

This page highlights key information. For complete eligibility criteria, study locations, investigator contacts, and the full protocol, visit the original record on ClinicalTrials.gov.

View NCT06257888 on ClinicalTrials.gov